Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme

Dendritic cell immunotherapy

(2013) Rachel Lubong Sabado et al.   Annals of the New York Academy of Sciences

Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients

(2013) Robert M. Prins et al.   JOURNAL OF IMMUNOTHERAPY

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

(2012) Hilko Ardon et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination

(2012) Steven De Vleeschouwer et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

(2012) T. Kimura et al.   Cancer Prevention Research

The efficacy of temozolomide for recurrent glioblastoma multiforme

(2012) Chao Chen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Human Monocytes Undergo Excessive Apoptosis following Temozolomide Activating the ATM/ATR Pathway While Dendritic Cells and Macrophages Are Resistant

(2012) Martina Bauer et al.   PLoS One

Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI

(2011) Yi-Ping Yang et al.   BIOMATERIALS

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

(2010) Michael J. Ciesielski et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Overview of Cellular Immunotherapy for Patients with Glioblastoma

(2010) Elodie Vauleon et al.   Clinical & Developmental Immunology

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study

(2010) James R. Perry et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era

(2010) Anthony J. Paravati et al.   JOURNAL OF NEURO-ONCOLOGY

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

(2010) J. H. Sampson et al.   NEURO-ONCOLOGY

EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

(2009) Bryan D. Choi et al.   BRAIN PATHOLOGY

Activated CD4+ T Cells Dramatically Enhance Chemotherapeutic Tumor Responses In Vitro and In Vivo

(2009) S. Radfar et al.   JOURNAL OF IMMUNOLOGY

Rechallenge with temozolomide in patients with recurrent gliomas

(2009) Antje Wick et al.   JOURNAL OF NEUROLOGY

Combined modality immunotherapy and chemotherapy: a new perspective

(2008) Rupal Ramakrishnan et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity

(2008) Rosaria Maria Rita Gangemi et al.   STEM CELLS